A new response-adaptive design for continuous treatment responses for phase III clinical trials (Q2431567)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: A new response-adaptive design for continuous treatment responses for phase III clinical trials |
scientific article; zbMATH DE number 5878790
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | A new response-adaptive design for continuous treatment responses for phase III clinical trials |
scientific article; zbMATH DE number 5878790 |
Statements
A new response-adaptive design for continuous treatment responses for phase III clinical trials (English)
0 references
15 April 2011
0 references
ethics
0 references
optimality
0 references
0.9017098546028136
0 references
0.8774049282073975
0 references
0.8704414367675781
0 references
0.8670777082443237
0 references
0.8501365780830383
0 references
